Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN's DMT studies

View:

Post by StockHawk1 on Mar 24, 2023 7:22pm

AGN's DMT studies

The phara-development company Algernon Pharmaceuticals (AGN.c AGNPF) is helping to pave the way in psychdelic medicine by studying if DMT can help patients with brain injuries. The company is doing this through 2 studies.

This first study (which is currently ongoing) has the goal of determining if DMT can help post-stroke patients. AGN is currently dosing healthy patients to define a safe and non-psychedelic dose of DMT. In the next phase of this study, AGN will give the determined safe dose to stroke survivors to study if/how it improves their brain health.

AGN has also planned a similar study which will examine if DMT can aid those with Traumatic Brain Injuries (TBI). The company is hoping to use data from its stroke study (such as the determined safe DMT dose) to expidite this study.

For more information, you can check out AGN's website here: https://algernonpharmaceuticals.com/

163